Page 10 - Herlev News Today

/PRNewswire/ -- Nordic Bioscience, a growing biomarker company, today announced the strengthening of its ongoing collaboration with Roche Diagnostics for the...

Denmark: The addition of SGLT2 inhibitor empagliflozin to guideline-directed HF therapy for 12 weeks did not improve left ventricular (LV) contractile reserve in patients with heart failure (HF) and...

Vupanorsen disappointed on triglyceride and non-HDL cholesterol reduction in TRANSLATE-TIMI 70, but post-hoc data on VLDL and remnant cholesterol point to a role for the class if not the drug, experts say.

The study counters other data suggesting high Lp(a) levels were only a problem in patients with systemic inflammation.

Evaxion Biotech A/S (NASDAQ:EVAX – Get Rating) and Valneva (NASDAQ:VALN – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk. Insider & Institutional Ownership 4.7% of Evaxion Biotech A/S […]

Cidara Therapeutics (NASDAQ:CDTX – Get Rating) and Evaxion Biotech A/S (NASDAQ:EVAX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Institutional & Insider Ownership 46.3% of Cidara Therapeutics […]

The authors say doctors who are safely prescribing both may be doing a good job of explaining how to avoid serious interactions.

There is a scarcity of real-world data showing that using both types of drugs together increases these risks.

MONDAY, April 18, 2022 (HealthDay News) — For men prescribed nitrates for ischemic heart disease (IHD), new prescriptions of phosphodiesterase type 5 (PDE5) inhibitors increased from 2000 to 2018, but an association between coprescription and adverse cardiovascular events was not observed, according to a study published online April 19 in the Annals of Internal Medicine. […]

Just when you think the men's 200m free was competitive enough one the senior level, the juniors upcoming are crushing some ridiculous times as well.